Download PDF
Der Nuklearmediziner 2006; 29(3): 159-165
DOI: 10.1055/s-2006-942133
Funktionell-morphologische Kombinationsbildgebung

© Georg Thieme Verlag Stuttgart · New York

Voraussetzungen und Möglichkeiten der Kombination von PET und MRT in der pädiatrischen Onkologie

Requirements and Possibilities of Combined PET and MRI in Pediatric OncologyT. Pfluger1 , K. Hahn1 , I. Schmid2 , A. Haug1 , M. Hacker1 , M. Weiss1
  • 1Klinik und Poliklinik für Nuklearmedizin, Ludwig-Maximilians-Universität München
  • 2Dr. von Haunersches Kinderspital, Ludwig-Maximilians-Universität München
Further Information

Publication History

Publication Date:
15 September 2006 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Mit zunehmender Verbreitung von kombinierten PET/CT-Geräten hat die multimodale nuklearmedizinisch-radiologische Bildgebung in den letzten Jahren Einzug in die klinische Routine gefunden. Speziell bei pädiatrischen und pädiatrisch-onkologischen Fragestellungen stellt jedoch die MRT die Methode der Wahl zur morphologischen Bildgebung dar. Im Rahmen dieser Übersicht werden die notwendigen Komponenten für die multimodale PET/MRT-Bildgebung, die Indikationen für pädiatrische MRT-Untersuchungen, Strategien der Bildanalyse und Bildpräsentation sowie die diagnostischen Erwartungen an die kombinierte Diagnostik und deren Limitationen vorgestellt und diskutiert.

Abstract

With increasing use of combined PET/CT scanners in the last few years, multimodality imaging (Nuclear Medicine/Radiology) found its way into clinical routine diagnostics. Especially in pediatric oncology, however, MRI is the modality of choice for morphological imaging. In this overview, necessary components for multimodality imaging, indications for pediatric MRI, strategies for image analysis and image presentation, and diagnostic goals and limitations of combined PET/MR-imaging are demonstrated and discussed.

Schlüsselwörter

multimodale Bildgebung - PET/MRT - Bildfusion - pädiatrische Onkologie

Key words

multimodality imaging - PET/MRI - image fusion - pediatric oncology

Literatur

  • 1 Connolly L P, Drubach L A, Ted Treves S. Applications of nuclear medicine in pediatric oncology.  Clin Nucl Med. 2002;  27 117-125
    CrossrefPubMedGoogle Scholar
  • 2 Schmidt G P, Baur-Melnyk A, Tiling R, Hahn K, Reiser M F, Schoenberg S O. Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system.  Radiologe. 2004;  44 889-898
    PubMedGoogle Scholar
  • 3 Bloem J L, van der Woude H J, Geirnaerdt M, Hogendoorn P C, Taminiau A H, Hermans J. Does magnetic resonance imaging make a difference for patients with musculoskeletal sarcoma?.  Br J Radiol. 1997;  70 327-337
    PubMedGoogle Scholar
  • 4 Bredella M A, Caputo G R, Steinbach L S. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.  AJR Am J Roentgenol. 2002;  179 1145-1150
    PubMedGoogle Scholar
  • 5 Antoch G, Vogt F M, Bockisch A, Ruehm S G. Whole-body tumor staging: MRI or FDG-PET/CT?.  Radiologe. 2004;  44 882-888
    PubMedGoogle Scholar
  • 6 Gaa J, Rummeny E J, Seemann M D. Whole-body imaging with PET/MRI.  Eur J Med Res. 2004;  9 309-312
    PubMedGoogle Scholar
  • 7 Pfluger T, Schmied C, Porn U, Leinsinger G, Vollmar C, Dresel S, Schmid I, Hahn K. Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma.  AJR Am J Roentgenol. 2003;  181 1115-1124
    PubMedGoogle Scholar
  • 8 Czernin J. Clinical applications of FDG-PET in oncology.  Acta Med Austriaca. 2002;  29 162-170
    CrossrefPubMedGoogle Scholar
  • 9 Alyafei S, Inoue T, Zhang H, Ahmed K, Oriuchi N, Sato N, Suzuki H, Endo K. Image fusion system using PACS for MRI, CT, and PET images.  Clin Positron Imaging. 1999;  2 137-143
    PubMedGoogle Scholar
  • 10 Hutton B F, Braun M. Software for image registration: algorithms, accuracy, efficacy.  Semin Nucl Med. 2003;  33 180-192
    CrossrefPubMedGoogle Scholar
  • 11 Slomka P J. Software approach to merging molecular with anatomic information.  J Nucl Med. 2004;  45 (Suppl 1) 36S-45S
    PubMedGoogle Scholar
  • 12 Pelizzari C A, Chen G T, Spelbring D R, Weichselbaum R R, Chen C T. Accurate three-dimensional registration of CT, PET, and/or MR images of the brain.  J Comput Assist Tomogr. 1989;  13 20-26
    PubMedGoogle Scholar
  • 13 Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P. Multimodality image registration by maximization of mutual information.  IEEE Trans Med Imaging. 1997;  16 187-198
    CrossrefPubMedGoogle Scholar
  • 14 Wells 3rd  W M, Viola P, Atsumi H, Nakajima S, Kikinis R. Multi-modal volume registration by maximization of mutual information.  Med Image Anal. 1996;  1 35-51
    CrossrefPubMedGoogle Scholar
  • 15 Skalski J, Wahl R L, Meyer C R. Comparison of mutual information-based warping accuracy for fusing body CT and PET by 2 methods: CT mapped onto PET emission scan versus CT mapped onto PET transmission scan.  J Nucl Med. 2002;  43 1184-1187
    PubMedGoogle Scholar
  • 16 Cohade C, Osman M, Marshall L N, Wahl R N. PET-CT: accuracy of PET and CT spatial registration of lung lesions.  Eur J Nucl Med Mol Imaging. 2003;  30 721-726 Epub 2003 Mar 1 
    CrossrefPubMedGoogle Scholar
  • 17 Stokking R, Zubal I G, Viergever M A. Display of fused images: methods, interpretation, and diagnostic improvements.  Semin Nucl Med. 2003;  33 219-227
    CrossrefPubMedGoogle Scholar
  • 18 Anderson H, Price P. What does positron emission tomography offer oncology?.  Eur J Cancer. 2000;  36 2028-2035
    CrossrefPubMedGoogle Scholar
  • 19 Bar-Shalom R, Valdivia A Y, Blaufox M D. PET imaging in oncology.  Semin Nucl Med. 2000;  30 150-185
    PubMedGoogle Scholar
  • 20 Czech N, Brenner W, Kampen W U, Henze E. [Diagnostic value of positron emission tomography (PET) in clinical oncology].  Dtsch Med Wochenschr. 2000;  125 565-567
    PubMedGoogle Scholar
  • 21 Delbeke D, Martin W H. Positron emission tomography imaging in oncology.  Radiol Clin North Am. 2001;  39 883-917
    CrossrefPubMedGoogle Scholar
  • 22 Mankoff D A, Bellon J R. Positron-emission tomographic imaging of cancer: glucose metabolism and beyond.  Semin Radiat Oncol. 2001;  11 16-27
    CrossrefPubMedGoogle Scholar
  • 23 Scott A M. Current status of positron emission tomography in oncology.  Intern Med J. 2001;  31 27-36
    CrossrefPubMedGoogle Scholar
  • 24 Brisse H, Ollivier L, Edeline V, Pacquement H, Michon J, Glorion C, Neuenschwander S. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.  Pediatr Radiol. 2004;  34 595-605 ,  Epub 2004 Apr 22
    PubMedGoogle Scholar
  • 25 Daldrup-Link H E, Franzius C, Link T M, Laukamp D, Sciuk J, Jurgens H, Schober O, Rummeny E J. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.  AJR Am J Roentgenol. 2001;  177 229-236
    PubMedGoogle Scholar
  • 26 Franzius C, Daldrup-Link H E, Wagner-Bohn A, Sciuk J, Heindel W L, Jurgens H, Schober O. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging.  Ann Oncol. 2002;  13 157-160
    CrossrefPubMedGoogle Scholar
  • 27 Hawkins D S, Rajendran J G, Conrad 3rd  E U, Bruckner J D, Eary J F. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.  Cancer. 2002;  94 3277-3284
    CrossrefPubMedGoogle Scholar
  • 28 Hudson M M, Krasin M J, Kaste S C. PET imaging in pediatric Hodgkin's lymphoma.  Pediatr Radiol. 2004;  34 190-198 ,  Epub 2004 Jan 27
    CrossrefPubMedGoogle Scholar
  • 29 Montravers F, McNamara D, Landman-Parker J, Grahek D, Kerrou K, Younsi N, Wioland M, Leverger G, Talbot J N. [(18)F]FDG in childhood lymphoma: clinical utility and impact on management.  Eur J Nucl Med Mol Imaging. 2002;  29 1155-1165 ,  Epub 2002 Jun 25
    CrossrefPubMedGoogle Scholar
  • 30 O'Hara S M, Donnelly L F, Coleman R E. Pediatric body applications of FDG PET.  AJR Am J Roentgenol. 1999;  172 1019-1024
    PubMedGoogle Scholar
  • 31 Shulkin B L. PET imaging in pediatric oncology.  Pediatr Radiol. 2004;  34 199-204 ,  Epub 2004 Jan 27
    CrossrefPubMedGoogle Scholar
  • 32 Shulkin B L, Mitchell D S, Ungar D R, Prakash D, Dole M G, Castle V P, Hernandez R J, Koeppe R A, Hutchinson R J. Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.  Radiology. 1995;  194 495-500
    PubMedGoogle Scholar
  • 33 Townsend D W, Cherry S R. Combining anatomy and function: the path to true image fusion.  Eur Radiol. 2001;  11 1968-1974
    CrossrefPubMedGoogle Scholar
  • 34 Pfluger T, Vollmar C, Porn U, Schmid R, Dresel S, Leinsinger G, Schmid I, Winkler P, Fischer S, Hahn K. Combined PET/MRI in cerebral and pediatric diagnostics.  Der Nuklearmediziner. 2002;  25 122-127
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Hueltenschmidt B, Sautter-Bihl M L, Lang O, Maul F D, Fischer J, Mergenthaler H G, Bihl H. Whole body positron emission tomography in the treatment of Hodgkin disease.  Cancer. 2001;  91 302-310
    CrossrefPubMedGoogle Scholar
  • 36 Torabi M, Aquino S L, Harisinghani M G. Current concepts in lymph node imaging.  J Nucl Med. 2004;  45 1509-1518
    PubMedGoogle Scholar
  • 37 Ilias I, Pacak K. Current approaches and recommended algorithm for the diagnostic localization of pheochromocytoma.  J Clin Endocrinol Metab. 2004;  89 479-491
    CrossrefPubMedGoogle Scholar
  • 38 Korholz D, Kluge R, Wickmann L, Hirsch W, Luders H, Lotz I, Dannenberg C, Hasenclever D, Dorffel W, Sabri O. Importance of F18-fluorodeoxy-D-2-glucose positron emission tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in childhood and adolescence - consequences for the GPOH-HD 2003 protocol.  Onkologie. 2003;  26 489-493
    CrossrefPubMedGoogle Scholar
  • 39 Popperl G, Lang S, Dagdelen O, Jager L, Tiling R, Hahn K, Tatsch K. Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer.  Rofo. 2002;  174 714-720
    PubMedGoogle Scholar

PD Dr. med. T. Pfluger

Klinik und Poliklinik für Nuklearmedizin · Ludwig-Maximilians-Universität München

Ziemssenstraße 1

80336 München

Phone: +49/89/51 60 24 23

Fax: +49/89/51 60 45 55

Email: Thomas.Pfluger@med.uni-muenchen.de

      >